• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例难治性川崎病合并假结核耶尔森菌感染经免疫抑制治疗后用头孢噻肟成功治愈的病例

A Case of Refractory Kawasaki Disease With Yersinia pseudotuberculosis Infection Successfully Treated With Cefotaxime Following Immunosuppressive Therapy.

作者信息

Yokoyama Koji, Sakabe Masahiko, Mamada Mitsukazu

机构信息

Department of Pediatrics, Japanese Red Cross Wakayama Medical Center, Wakayama, JPN.

出版信息

Cureus. 2024 Nov 17;16(11):e73866. doi: 10.7759/cureus.73866. eCollection 2024 Nov.

DOI:10.7759/cureus.73866
PMID:39697956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11652116/
Abstract

Kawasaki disease (KD) is a vasculitis mainly affecting children under five, with symptoms such as persistent fever, rash, red lips, strawberry tongue, conjunctivitis, and swollen hands and feet. Diagnosis is based on a fever lasting over five days plus at least four of these symptoms. Treatment includes intravenous immunoglobulin (IVIG) and aspirin to reduce complications, especially coronary artery issues.  infection is a gram-negative bacterium. In KD patients, the most prevalent gastrointestinal symptoms were vomiting (28.9%), abdominal pain (17.4%), and diarrhea (16.9%). By contrast, diarrhea is observed in over 50% of patients with  infection.  is a gram-negative bacterium reported to infect a wide variety of animal hosts and contact with these animals can serve as a potential clue in diagnosis.  infection can mimic KD with similar fever and rash symptoms, posing a diagnostic challenge. In practice, however, differentiation remains challenging. Differentiating between KD and  is essential, especially in cases resistant to typical KD treatment. Distinguishing KD from  infection in clinical practice is crucial to prevent misdiagnosis, avoid unnecessary immunosuppression, and minimize delays in effective treatment. Misinterpreting  infection as KD may lead to inappropriate treatment strategies that fail to address the underlying infection, potentially resulting in adverse patient outcomes. Accurate and timely diagnosis is therefore essential to initiate appropriate therapeutic interventions. A 16-month-old boy presented with fever and diarrhea and was initially treated for infectious gastroenteritis, with elevated inflammatory markers noted (C-reactive protein (CRP) 4.47 mg/dL, white blood cell (WBC) 8,200/μL). As his condition progressed, he developed symptoms consistent with KD, including a rash and mucous membrane changes, and was treated with IVIG and aspirin. However, the fever persisted, and elevated inflammatory markers continued (CRP 3.93 mg/dL, WBC 9,700/μL), prompting additional immunosuppressive therapies for refractory KD. Ultrasound revealed gastrointestinal and lymph node abnormalities suggestive of vasculitis. Eventually, infection was confirmed through serology, and antibiotic treatment was reintroduced, leading to defervescence. This case highlights the challenge of distinguishing KD from infection because they can coexist, complicating treatment decisions. Rapid diagnostic methods for , specifically through loop-mediated isothermal amplification-polymerase chain reaction (LAMP-PCR) testing, are crucial to guide timely treatment, particularly given the risk of coronary artery complications associated with both conditions.

摘要

川崎病(KD)是一种主要影响五岁以下儿童的血管炎,症状包括持续发热、皮疹、嘴唇发红、草莓舌、结膜炎以及手脚肿胀。诊断基于持续发热超过五天加上至少出现上述四种症状。治疗包括静脉注射免疫球蛋白(IVIG)和阿司匹林,以减少并发症,尤其是冠状动脉问题。 感染是一种革兰氏阴性菌。在KD患者中,最常见的胃肠道症状是呕吐(28.9%)、腹痛(17.4%)和腹泻(16.9%)。相比之下,超过50%的 感染患者会出现腹泻。 是一种革兰氏阴性菌,据报道可感染多种动物宿主,与这些动物接触可能是诊断的一个潜在线索。 感染可出现类似发热和皮疹的症状,酷似KD,这给诊断带来了挑战。然而在实际中,进行区分仍然具有挑战性。区分KD和 至关重要,尤其是在对典型KD治疗有抵抗的病例中。在临床实践中区分KD和 感染对于防止误诊、避免不必要的免疫抑制以及尽量减少有效治疗的延误至关重要。将 感染误诊为KD可能导致未能针对潜在感染的不恰当治疗策略,可能给患者带来不良后果。因此,准确及时的诊断对于启动适当的治疗干预至关重要。一名16个月大的男孩出现发热和腹泻,最初被诊断为感染性肠胃炎进行治疗,当时炎症指标升高(C反应蛋白(CRP)4.47mg/dL,白细胞(WBC)8200/μL)。随着病情进展,他出现了与KD相符的症状,包括皮疹和黏膜变化,并接受了IVIG和阿司匹林治疗。然而,发热持续,炎症指标持续升高(CRP 3.93mg/dL,WBC 9700/μL),促使对难治性KD采用额外的免疫抑制疗法。超声检查显示胃肠道和淋巴结异常,提示血管炎。最终,通过血清学确诊为 感染,并重新采用抗生素治疗,随后体温恢复正常。该病例凸显了区分KD和 感染的挑战,因为它们可能同时存在,使治疗决策变得复杂。针对 的快速诊断方法,特别是通过环介导等温扩增-聚合酶链反应(LAMP-PCR)检测,对于指导及时治疗至关重要,尤其是考虑到两种疾病都存在冠状动脉并发症的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac2/11652116/e2edec5da7aa/cureus-0016-00000073866-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac2/11652116/3963272552b4/cureus-0016-00000073866-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac2/11652116/8f9e79689a28/cureus-0016-00000073866-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac2/11652116/e2edec5da7aa/cureus-0016-00000073866-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac2/11652116/3963272552b4/cureus-0016-00000073866-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac2/11652116/8f9e79689a28/cureus-0016-00000073866-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ac2/11652116/e2edec5da7aa/cureus-0016-00000073866-i03.jpg

相似文献

1
A Case of Refractory Kawasaki Disease With Yersinia pseudotuberculosis Infection Successfully Treated With Cefotaxime Following Immunosuppressive Therapy.1例难治性川崎病合并假结核耶尔森菌感染经免疫抑制治疗后用头孢噻肟成功治愈的病例
Cureus. 2024 Nov 17;16(11):e73866. doi: 10.7759/cureus.73866. eCollection 2024 Nov.
2
Intravenous immunoglobulin for the treatment of Kawasaki disease.静脉注射免疫球蛋白治疗川崎病。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
3
Clinical features analysis of Kawasaki disease with abdominal symptoms as the first manifestation.以腹部症状为首发表现的川崎病临床特征分析
Eur J Pediatr. 2023 Sep;182(9):4049-4057. doi: 10.1007/s00431-023-05086-x. Epub 2023 Jul 3.
4
Kawasaki disease: a comprehensive review of treatment options.川崎病:治疗选择的全面综述
J Clin Pharm Ther. 2015 Dec;40(6):620-5. doi: 10.1111/jcpt.12334. Epub 2015 Nov 7.
5
Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: A case report.单卵双胞胎急性人腺病毒感染后同时发生川崎病:一例报告
Pediatr Rheumatol Online J. 2017 May 16;15(1):39. doi: 10.1186/s12969-017-0169-x.
6
Kawasaki disease with a concomitant primary Epstein - Barr virus infection.川崎病合并原发性 EBV 感染。
Pediatr Rheumatol Online J. 2020 Aug 12;18(1):65. doi: 10.1186/s12969-020-00459-0.
7
Yersinia pseudotuberculosis Infection Accompanied by Intussusception and Incomplete Kawasaki Disease in a 7-year-old Girl.7 岁女童患耶尔森菌假结核感染伴肠套叠及不完全川崎病
Keio J Med. 2022 Jun 25;71(2):50-52. doi: 10.2302/kjm.2021-0002-CR. Epub 2021 Jun 8.
8
Yersinia pseudotuberculosis-Associated Myositis.耶尔森氏假结核菌相关性肌炎
Cureus. 2024 Nov 10;16(11):e73399. doi: 10.7759/cureus.73399. eCollection 2024 Nov.
9
Atypical Kawasaki Disease Presentation in a Previously Healthy Infant: A Diagnostic Challenge.一名既往健康婴儿的非典型川崎病表现:诊断挑战
Cureus. 2023 Oct 9;15(10):e46748. doi: 10.7759/cureus.46748. eCollection 2023 Oct.
10
A Sri Lankan infant with immunoglobulin resistant incomplete Kawasaki disease with a vesicular psoriasiform rash, hypertension and late onset small joint arthritis: a case report.一名斯里兰卡婴儿患有免疫球蛋白耐药性不完全川崎病,伴有水疱样银屑病样皮疹、高血压和迟发性小关节关节炎:一例报告。
BMC Pediatr. 2022 Jul 23;22(1):444. doi: 10.1186/s12887-022-03510-z.

本文引用的文献

1
The etiologies of Kawasaki disease.川崎病的病因。
J Clin Invest. 2024 Mar 1;134(5):e176938. doi: 10.1172/JCI176938.
2
A TNF-IL-1 circuit controls Yersinia within intestinal pyogranulomas.TNF-IL-1 回路控制肠道脓性肉芽肿中的耶尔森菌。
J Exp Med. 2024 Mar 4;221(3). doi: 10.1084/jem.20230679. Epub 2024 Feb 16.
3
Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers.血清细胞因子谱在鉴别川崎病及其类似物中的临床意义。
Cytokine. 2023 Sep;169:156280. doi: 10.1016/j.cyto.2023.156280. Epub 2023 Jun 23.
4
Overview of Guidelines for the Medical Treatment of Acute Kawasaki Disease in Japan (2020 Revised Version) and Positioning of Plasma Exchange Therapy in the Acute Phase.日本急性川崎病医学治疗指南(2020修订版)概述及急性期血浆置换疗法的定位
Pediatr Infect Dis J. 2023 Sep 1;42(9):e328-e332. doi: 10.1097/INF.0000000000003974. Epub 2023 May 18.
5
Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease.多种静脉用抗生素的使用与川崎病静脉用免疫球蛋白耐药相关。
Pediatr Neonatol. 2022 Mar;63(2):117-124. doi: 10.1016/j.pedneo.2021.06.020. Epub 2021 Oct 12.
6
A Case of Intravenous Immunoglobulin-Resistant Kawasaki Disease With Yersinia enterocolitica Enterocolitis Successfully Treated With Cefotaxime Following Infliximab and Cyclosporine.一例静脉注射免疫球蛋白抵抗性川崎病合并小肠结肠炎耶尔森菌肠炎,在英夫利昔单抗和环孢素治疗后,头孢噻肟成功治愈
J Pediatric Infect Dis Soc. 2021 Mar 26;10(2):225-226. doi: 10.1093/jpids/piaa034.
7
Aetiological Significance of Infectious Stimuli in Kawasaki Disease.川崎病中感染性刺激的病因学意义
Front Pediatr. 2019 Jun 28;7:244. doi: 10.3389/fped.2019.00244. eCollection 2019.
8
Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease.嵌套病例对照研究炎症性肠病患者机会性感染的危险因素。
World J Gastroenterol. 2019 May 14;25(18):2240-2250. doi: 10.3748/wjg.v25.i18.2240.
9
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.白细胞介素-6 易于成为预测川崎病不完全反应和免疫球蛋白静脉注射无反应的候选生物标志物,而非冠状动脉瘤。
Clin Exp Med. 2019 May;19(2):173-181. doi: 10.1007/s10238-018-00544-5. Epub 2019 Jan 8.
10
Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.川崎病:意大利儿科学会指南,第一部分-定义、流行病学、病因发病机制、急性期临床表现和治疗。
Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.